Thursday, December 15, 2005

Parting Is Such Sweet Sorrow

Today GlobeImmune finished packing and said good bye to the Fitzsimons Redevelopment Authority. Early pre-clinical success, human Phase I clinical trials, multiple rounds of capital raising and hiring have culminated in the need for additional space that Fitzsimons, in its current state, was unable to provide to the accelerating start-up. Another way to look at the departure is the FRA met its expectations in incubating this once seed-stage endeavor and can consider the move a very successful graduation. Kudos to all. We look forward to monitoring the progress of GlobeImmune and their Tarmogen™ technology.

No comments: